The {pharmaceutical market is increasingly exploring alternative treatment methods for obesity , and the introduction of semaglutide 10mg doses represents a significant development . Clinicians are beginning to evaluate the potential benefits and drawbacks associated with this higher strength product, notably in relation to existing lower-dose sema